Aurora Innovation (NASDAQ:AUR) Stock

AURORA INNOVATION INC

Aurora Innovation

Aurora Innovation Inc delivers self-driving technology safely, quickly, and broadly. The Aurora Driver is a self-driving system designed to operate multiple vehicle types, from freight-hauling trucks to ride-hailing passenger vehicles. It underpins Aurora Horizon and Aurora Connect, its driver-as-a-service products for trucking and ride-hailing. The Company is developing the Aurora Driver, an advanced and scalable suite of self-driving hardware, software, and data services designed as a platform to adapt and interoperate among vehicle types and applications.

Aurora Innovation, Inc. - Class A Common Stock

Aurora Innovation Inc

Aura Biosciences Inc

AURORA ACQUISITION CORP CL A

Auri Inc

AURUM MEGAMETALS CORP by Aurum Megametals Corp.

Aurum Megametals Corp

Aurion Biotech Inc

Aurora - United States Dollar

AURELIUS MINERALS INC by Aurelius Minerals Inc.

Aurelius Minerals Inc

Attune RTD

Aurwest Resources Corp

NUO THERAPEUTICS INC NEW by Nuo Therapeutics, Inc.

Nuo Therapeutics Inc

Aurory

Although we may never see <a href="https://www.benzinga.com/markets/equities/25/05/45385807/is-trumps-tariff-push-catalyzing-global-trade-realignment-china-eu-recalibrate-ties">trade tariffs</a> with the United States fall to prior levels, at least during President Trump's second term, the soothing of tensions between the US and Asia could be the catalyst for a resumption of the region's burgeoning artificial intelligence industry.&nbsp;
Asia-Pacific markets rallied on the news that China and the US had agreed to a trade deal that included a 90-day pause on tariffs and a 115% drop on prior reciprocal tariffs. 
The news saw Hong Kong's Hang Seng Index climb 2.3%, while Korea Republic's KOSPI Index also posted healthy 1.23% gains. However, analysts have been quick to warn anyone believing that it'll be smooth sailing throughout the region off the back of the positive news.&nbsp;
Julius Baer strategists have suggested that a rollback of tariffs to pre-conflict levels is ‘unlikely', stating that any new deals announced are likely to involve ‘complex conditions and protracted implementation timelines,' which could dampen APAC's economic recovery from the shock of tariffs. 
Despite this, the news of a tariffs de-escalation will undoubtedly be welcomed throughout the region, particularly after Morgan Stanley suggested that trade risk could see Asian tech stocks fall 20%.&nbsp;
Prior to the announcement of President Trump's so-called reciprocal tariffs, Chinese tech stocks listed in Hong Kong had posted their best weekly winning streak since 2020 following an impressive earnings season throughout the nation's artificial intelligence sector that drew international investor interest.&nbsp;
Given the disruption of the trade levies, which climbed as high as 145% during the peak of the conflict between the United States and China, there's renewed hope that the region can return to its prosperous outlook built on AI innovation.&nbsp;
<h2 class="wp-block-heading">Bullish Sentiment Returns to APAC</h2>
The trade war with the United States threatened to hamper a wave of strong market sentiment sweeping through the Asia-Pacific region following DeepSeek's artificial intelligence breakthrough in China.&nbsp;
Buoyed by the success of DeepSeek and the rollout of government stimulus intended to drive innovation, China's tech sector appears to be booming.&nbsp;
By March, the MSCI China Index had <a href="https://www.chinadaily.com.cn/a/202503/13/WS67d22d31a310c240449da81a.html">climbed almost 18%</a> before tariff uncertainty caused a significant retracing of its growth. Likewise, February saw a total net capital inflow of $3.8 billion into Chinese stocks, according to Morgan Stanley data.&nbsp;
It's these positive market movements that have enabled firms like Tianju Dihe (Suzhou) Data Co. Ltd. (2479.HK) to post increasingly optimistic profit growth forecasts amid China's growing tech sector.&nbsp;
In a recent filing, Tianju Dihe announced that it expects to post a net profit of 50 million yuan ($6.9 million) to 53 million yuan for last year, up 43% to 51% from 2023 after the company went public in Hong Kong last year.&nbsp;
The company, which attributes much of its revenue increase to its core application programming interface (API), is an example of how APAC's prosperous AI landscape can be the tide that raises all boats throughout the region's tech sector.&nbsp;
<h2 class="wp-block-heading">China's AI Boom</h2>
There's no getting away from China's impact on the Asia-Pacific region's artificial intelligence boom. The nation's government recently announced plans to invest 10 trillion yuan ($1.4 trillion) over the next 15 years in a bid to gain an edge in advanced technology.&nbsp;
January saw the launch of a <a href="https://www.bbc.co.uk/news/articles/ckg8jqj393eo">60 billion yuan</a> investment fund domestically, in a move that could help to counter the threat of US hostility towards Chinese AI initiatives.&nbsp;
The fund was launched just days after the United States tightened export controls for its advanced chips, placing more Chinese firms on a trade blacklist as part of its ongoing security concerns.&nbsp;
These initiatives come as China appears determined to <a href="https://www.reuters.com/world/china/chinas-parliament-meets-shield-economy-us-tariff-salvos-2025-03-04/">secure 5% growth</a> in 2025, even as the US continues to bring tariff uncertainty to international trade.&nbsp;
Asia-Pacific countries have also been strengthening their positions amidst the AI boom and now account for a significant volume of the world's semiconductor fabrication.&nbsp;
Regional leaders like China, Taiwan, Japan, and the Republic of Korea are forecasted to account for 75% of the world's semiconductor manufacturing in 2025. It's this industrial strength that's helping the region to become an attractive place for global businesses to grow their operations. 
It's also paving the way for more non-domestic businesses to explore their options for <a href="https://msadvisory.com/resource/doing-business-in-china/">Chinese market entry</a> and growth as a strategy to tap into the region's flourishing tech landscape.&nbsp;
We're even seeing US market leaders like Nvidia navigating trade uncertainty on both sides of the Pacific by adapting its H20 AI chip to become compliant with US export regulations after its initial product was banned.&nbsp;
It's this commitment to embracing the Asia-Pacific region that's driving optimism for its future AI capabilities.&nbsp;
<h2 class="wp-block-heading">Uncertainty Still Lingers</h2>
While the future looks bright for Asia-Pacific AI initiatives, it's worth noting that the outcome of the United States' trade <a href="https://www.benzinga.com/personal-finance/25/05/45408434/bill-ackman-says-the-rift-is-healing-as-china-opens-door-to-90-day-tariff-pause-urges-trump-to-lower-levies-to-10">tariffs following their 90-day postponement</a> will be decisive for the region's market growth over the foreseeable future.&nbsp;
Although we're seeing signs of tech resilience that indicate APAC's brightest tech stocks will remain resilient in the face of tariffs, a full de-escalation could be the catalyst for real growth. Clearing skies for trade prospects could help to drive growth throughout China and beyond and can solidify the region's status as a key player in the artificial intelligence boom period.
Disclosure: On the date of publication, Dmytro Spilka did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer. Dmytro Spilka does not intend to make a trade in any of the securities mentioned above in the next 72 hours.

Equities

Government

Global

Econ #s

Opinion

Markets

De-Escalating Trade Tensions In Asia-Pacific Will Reinforce Regional AI Opportunities

Luminar Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LAZR#NASDAQ">LAZR</a>) reported quarterly losses of $(1.50) per share which beat the analyst consensus estimate of $(1.78) by 15.73 percent. This is a 47.18 percent increase over losses of $(2.84) per share from the same period last year. The company reported quarterly sales of $18.89 million which beat the analyst consensus estimate of $15.98 million by 18.19 percent. This is a 9.93 percent decrease over sales of $20.97 million the same period last year.

Earnings

Earnings Beats

News

LAZR

Luminar Technologies Q1 Adj. EPS $(1.50) Beats $(1.78) Estimate, Sales $18.89M Beat $15.98M Estimate

IREN Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IREN#NASDAQ">IREN</a>) reported financial results for the third quarter of fiscal 2025 on Wednesday after the bell. Here&#8217;s a look at the key details <a href="https://www.benzinga.com/pressreleases/25/05/g45420012/iren-reports-q3-fy25-results">from the report</a>.
Q3 Earnings: IREN reported first-quarter revenue of $148.1 million, missing analyst <a href="http://benzinga.com/quote/IREN/earnings">estimates</a> of $159.37 million, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>. The company said $141.2 million in revenue came from its Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) mining operations, up 24% year-over-year.
IREN said it mined 1,514 Bitcoin during the quarter, up from 1,347 Bitcoin mined in the second quarter. Total electricity costs increased from $28.9 million to $36.5 million quarter-over-quarter. The company reported an average operating hashrate of 29.4 EH/s in the quarter.
IREN ended the quarter with $184.3 million in cash and cash equivalents. 
&#8220;We&#8217;re pleased to report another quarter of strong EBITDA and net profit. Our focus on large-scale data center sites continues to drive rapid growth and strong margins,&#8221; said Daniel Roberts, co-founder and co-CEO of IREN.
Outlook: IREN expects its installed capacity to reach 50 EH/s by June 30. The company noted that it climbed to 40 EH/s as of April 16. 
IREN said it continues to evaluate expansion opportunities as its customer growth strengthens, supporting its AI colocation pipeline. IREN expects to deliver its 50MW liquid-cooled AI data center in the fourth quarter.
IREN Price Action: <a href="http://benzinga.com/quote/IREN">IREN Limited shares</a> were up 3.76% in Wednesday&#8217;s after-hours session, trading at $8.27 at the time of publication, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45416194/bitcoins-volatility-makes-it-unfit-as-a-benchmark-for-liquid-funds-report">Bitcoin&#8217;s Volatility Makes It Unfit As A Benchmark For Liquid Funds: Report</a></li>
</ul>
Photo: Shutterstock.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

After-Hours Center

Movers

$BTC

IREN

IREN Reports Q3 Earnings: Bitcoin Mining Revenue Jumps 24%, Company Targeting 50 EH/s By End Of June, Shares Move Higher

PRO REIT (TSX:<a class="ticker" href="https://www.benzinga.com/stock/PRV#TSX">PRV</a>) reported quarterly earnings of $0.12 per share. This is a 2.46 percent decrease over earnings of $0.12 per share from the same period last year. The company reported $25.74 million in sales this quarter. This is a 0.14 percent increase over sales of $25.70 million the same period last year.

TSX:PRV

PRO REIT Q1 FFO $0.12 Down From $0.12 YoY, Sales $25.74M Up From $25.70M YoY

Stardust Power (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SDST#NASDAQ">SDST</a>) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0.06) by 16.67 percent. This is a 75 percent decrease over losses of $(0.04) per share from the same period last year.

Earnings Misses

SDST

Stardust Power Q1 EPS $(0.07) Misses $(0.06) Estimate

<h3>Gainers</h3>
<ul>
<li>Beachbody Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BODI#NYSE">BODI</a>) shares rose 16.8% to $5.5 during Wednesday's after-market session. The market value of their outstanding shares is at $38.4 million. As per the press release, Q1 earnings came out today. </li>
<li>Boot Barn Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOOT#NYSE">BOOT</a>) shares increased by 14.19% to $151.69. The market value of their outstanding shares is at $4.6 billion. As per the press release, Q4 earnings came out today. </li>
<li>Birks Group (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BGI#AMEX">BGI</a>) stock rose 11.23% to $1.09. The company's market cap stands at $20.9 million. </li>
<li>XWELL (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XWEL#NASDAQ">XWEL</a>) stock rose 8.69% to $1.0. The company's market cap stands at $5.2 million. </li>
<li>ECD Automotive Design (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ECDA#NASDAQ">ECDA</a>) shares rose 6.75% to $0.4. The market value of their outstanding shares is at $13.9 million. </li>
<li>Lazydays Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GORV#NASDAQ">GORV</a>) shares moved upwards by 6.25% to $0.17. The company's market cap stands at $18.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Lulus Fashion Lounge (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LVLU#NASDAQ">LVLU</a>) stock fell 14.0% to $0.36 during Wednesday's after-market session. The market value of their outstanding shares is at $15.5 million. As per the news, the Q1 earnings report came out today. </li>
<li>Mingteng International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTEN#NASDAQ">MTEN</a>) shares decreased by 10.28% to $12.99. The company's market cap stands at $88.8 million. </li>
<li>Top Win International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TOPW#NASDAQ">TOPW</a>) stock declined by 6.72% to $6.11. The company's market cap stands at $151.9 million. </li>
<li>Ruanyun Edai Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RYET#NASDAQ">RYET</a>) shares declined by 6.06% to $9.0. The company's market cap stands at $303.7 million. </li>
<li>Cheetah Net Supply Chain (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTNT#NASDAQ">CTNT</a>) stock fell 6.03% to $1.56. The market value of their outstanding shares is at $5.0 million. </li>
<li>Destination XL Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXLG#NASDAQ">DXLG</a>) shares decreased by 5.22% to $1.0. The company's market cap stands at $53.5 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

The Beachbody Company, Inc. Class A Common Stock

BODI

BOOT

CTNT

DXLG

ECDA

GORV

LVLU

MTEN

RYET

TOPW

XWEL

12 Consumer Discretionary Stocks Moving In Wednesday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Accelerate Diagnostics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AXDX#NASDAQ">AXDX</a>) stock moved upwards by 202.1% to $0.1 during Wednesday's after-market session. The market value of their outstanding shares is at $2.5 million. </li>
<li>Aytu BioPharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AYTU#NASDAQ">AYTU</a>) stock moved upwards by 53.33% to $2.07. The company's market cap stands at $12.7 million. As per the news, the Q3 earnings report came out today. </li>
<li>Bionano Genomics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNGO#NASDAQ">BNGO</a>) stock moved upwards by 30.21% to $4.87. The company's market cap stands at $13.3 million. As per the press release, Q1 earnings came out today. </li>
<li>ImmuCell (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICCC#NASDAQ">ICCC</a>) stock increased by 21.46% to $5.96. The company's market cap stands at $53.6 million. The company's, Q1 earnings came out today. </li>
<li>CARISMA Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CARM#NASDAQ">CARM</a>) stock moved upwards by 19.23% to $0.23. The company's market cap stands at $9.6 million. The company's, Q1 earnings came out yesterday. </li>
<li>Klotho Neurosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KLTO#NASDAQ">KLTO</a>) shares moved upwards by 15.69% to $0.33. The company's market cap stands at $9.5 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Onconetix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONCO#NASDAQ">ONCO</a>) stock declined by 11.3% to $0.09 during Wednesday's after-market session. The market value of their outstanding shares is at $1.2 million. </li>
<li>Channel Therapeutics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CHRO#AMEX">CHRO</a>) stock declined by 8.97% to $0.96. The market value of their outstanding shares is at $5.8 million. As per the news, the Q1 earnings report came out yesterday. </li>
<li>Citius Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTXR#NASDAQ">CTXR</a>) stock decreased by 7.25% to $0.87. The market value of their outstanding shares is at $8.1 million. As per the news, the Q2 earnings report came out today. </li>
<li>TNF Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNFA#NASDAQ">TNFA</a>) stock declined by 6.99% to $0.21. The market value of their outstanding shares is at $2.0 million. </li>
<li>Avalo Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVTX#NASDAQ">AVTX</a>) stock decreased by 6.95% to $3.35. The company's market cap stands at $35.7 million. As per the press release, Q1 earnings came out 2 days ago. </li>
<li>Codexis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDXS#NASDAQ">CDXS</a>) shares decreased by 6.48% to $2.31. The company's market cap stands at $191.3 million. The company's, Q1 earnings came out today. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AVTX

AXDX

AYTU

BNGO

CARM

CDXS

CHRO

CTXR

ICCC

KLTO

ONCO

TNFA

12 Health Care Stocks Moving In Wednesday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Graphjet Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTI#NASDAQ">GTI</a>) stock rose 77.4% to $0.17 during Wednesday's after-market session. The company's market cap stands at $25.2 million. </li>
<li>Innovative Solns (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISSC#NASDAQ">ISSC</a>) shares increased by 35.37% to $9.95. The company's market cap stands at $174.5 million. The company's, Q2 earnings came out today. </li>
<li>Dragonfly Energy Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DFLI#NASDAQ">DFLI</a>) stock rose 10.19% to $0.47. The company's market cap stands at $3.4 million. </li>
<li>ZJK Industrial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZJK#NASDAQ">ZJK</a>) stock moved upwards by 10.19% to $4.97. The company's market cap stands at $305.0 million. </li>
<li>ClearSign Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLIR#NASDAQ">CLIR</a>) stock rose 10.0% to $0.68. The market value of their outstanding shares is at $34.2 million. </li>
<li>PAMT (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAMT#NASDAQ">PAMT</a>) shares rose 7.72% to $14.5. The company's market cap stands at $315.9 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Primega Group Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PGHL#NASDAQ">PGHL</a>) stock decreased by 29.0% to $0.7 during Wednesday's after-market session. The market value of their outstanding shares is at $18.6 million. </li>
<li>Shoals Technologies Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHLS#NASDAQ">SHLS</a>) shares decreased by 17.19% to $5.06. The company's market cap stands at $845.9 million. </li>
<li>High-Trend International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTCO#NASDAQ">HTCO</a>) shares fell 14.41% to $0.34. The company's market cap stands at $41.4 million. </li>
<li>Orion Group Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORN#NYSE">ORN</a>) shares decreased by 10.41% to $7.75. The market value of their outstanding shares is at $302.1 million. </li>
<li>Lichen International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LICN#NASDAQ">LICN</a>) stock declined by 5.29% to $5.56. The company's market cap stands at $3.3 million. </li>
<li>Hong Kong Pharma Digital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HKPD#NASDAQ">HKPD</a>) shares decreased by 5.18% to $1.02. The market value of their outstanding shares is at $11.2 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CLIR

DFLI

HKPD

HTCO

ISSC

LICN

PAMT

PGHL

SHLS

12 Industrials Stocks Moving In Wednesday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>908 Devices (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MASS#NASDAQ">MASS</a>) shares moved upwards by 7.6% to $4.65 during Wednesday's after-market session. The company's market cap stands at $166.1 million. As per the press release, Q1 earnings came out yesterday. </li>
<li>CoreWeave (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWV#NASDAQ">CRWV</a>) shares increased by 7.15% to $72.29. The company's market cap stands at $33.6 billion. As per the press release, Q1 earnings came out today. </li>
<li>Lightwave Logic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LWLG#NASDAQ">LWLG</a>) stock moved upwards by 6.11% to $1.06. The market value of their outstanding shares is at $132.0 million. As per the press release, Q1 earnings came out yesterday. </li>
<li>Blaize Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BZAI#NASDAQ">BZAI</a>) stock increased by 5.75% to $2.94. The company's market cap stands at $298.9 million. As per the press release, Q1 earnings came out today. </li>
<li>Boxlight (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BOXL#NASDAQ">BOXL</a>) shares increased by 5.62% to $1.69. The market value of their outstanding shares is at $3.7 million. As per the press release, Q1 earnings came out today. </li>
<li>Karooooo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KARO#NASDAQ">KARO</a>) stock moved upwards by 5.34% to $47.3. The market value of their outstanding shares is at $1.4 billion. The company's, Q4 earnings came out today. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Saverone 2014 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SVRE#NASDAQ">SVRE</a>) stock declined by 18.8% to $1.51 during Wednesday's after-market session. </li>
<li>GCT Semiconductor Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GCTS#NYSE">GCTS</a>) shares fell 17.28% to $1.82. The market value of their outstanding shares is at $87.8 million. As per the news, the Q1 earnings report came out today. </li>
<li>Rekor Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REKR#NASDAQ">REKR</a>) stock declined by 14.71% to $0.87. The market value of their outstanding shares is at $91.6 million. As per the news, the Q1 earnings report came out today. </li>
<li>DXC Technology (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DXC#NYSE">DXC</a>) shares declined by 12.56% to $14.48. The company's market cap stands at $2.6 billion. The company's, Q4 earnings came out today. </li>
<li>Red Cat Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RCAT#NASDAQ">RCAT</a>) shares declined by 7.37% to $6.16. The company's market cap stands at $557.5 million. As per the press release, Q1 earnings came out today. </li>
<li>Soluna Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLNH#NASDAQ">SLNH</a>) shares decreased by 4.6% to $0.82. The company's market cap stands at $10.2 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BOXL

BZAI

CRWV

GCTS

KARO

LWLG

MASS

RCAT

REKR

SLNH

SVRE

12 Information Technology Stocks Moving In Wednesday's After-Market Session

Blaize Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BZAI#NASDAQ">BZAI</a>) reported quarterly losses of $(1.61) per share. This is a 30.89 percent decrease over losses of $(1.23) per share from the same period last year. The company reported $1.01 million in sales this quarter. This is a 83.42 percent increase over sales of $549.00 thousand the same period last year.

Blaize Holdings Q1 EPS $(1.61) Down From $(1.23) YoY, Sales $1.01M Up From $549.00K YoY

–Data Demonstrated Statistically Significant Improvements in Primary and Secondary Endpoints with Most Subjects Achieving Near Normal Ranges of Wakefulness and Clinically Meaningful Improvements Across the Broad Range of Symptoms Investigated
–Oveporexton Found to be Generally Safe and Well Tolerated
–Phase 3 Readout of Oveporexton Anticipated in 2025

Biotech

General

Takeda Pharmaceutical Data From Phase 2b Trial Of Oveporexton In People With Narcolepsy Type 1 Published In New England Journal Of Medicine

GameSquare Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GAME#NASDAQ">GAME</a>) is gearing up to announce its quarterly earnings on Thursday, 2025-05-15. Here's a quick overview of what investors should know before the release.
Analysts are estimating that GameSquare Holdings will report an earnings per share (EPS) of $-0.09.
GameSquare Holdings bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Overview of Past Earnings</h3>
The company's EPS missed by $0.73 in the last quarter, leading to a 5.88% drop in the share price on the following day.
Here's a look at GameSquare Holdings's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.08</td>
<td>-0.14</td>
<td>-0.09</td>
<td>-0.29</td>
<td>-0.23</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.81</td>
<td>-0.15</td>
<td>-0.38</td>
<td>-0.39</td>
<td>-1.37</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-6.0%</td>
<td>-15.0%</td>
<td>4.0%</td>
<td>1.0%</td>
<td>-27.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1747256628_0.png" alt="eps graph" />
<h3>Tracking GameSquare Holdings's Stock Performance</h3>
Shares of GameSquare Holdings were trading at $0.6239 as of May 13. Over the last 52-week period, shares are down 53.65%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<a href="https://www.benzinga.com/quote/GAME/earnings">To track all earnings releases for GameSquare Holdings visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

GAME

A Look Ahead: GameSquare Holdings's Earnings Forecast

Reliance Global Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RELI#NASDAQ">RELI</a>) reported quarterly losses of $(0.66) per share. This is a 95.21 percent increase over losses of $(13.77) per share from the same period last year. The company reported $4.24 million in sales this quarter. This is a 3.77 percent increase over sales of $4.08 million the same period last year.

RELI

Reliance Global Group Q1 EPS $(0.66) Up From $(13.77) YoY, Sales $4.24M Up From $4.08M YoY

American Shared Hospital (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AMS#AMEX">AMS</a>) is gearing up to announce its quarterly earnings on Thursday, 2025-05-15. Here's a quick overview of what investors should know before the release.
Analysts are estimating that American Shared Hospital will report an earnings per share (EPS) of $0.04.
Anticipation surrounds American Shared Hospital's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
<h3>Earnings Track Record</h3>
In the previous earnings release, the company missed EPS by $0.21, leading to a 0.0% drop in the share price the following trading session.
Here's a look at American Shared Hospital's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.01</td>
<td>0.08</td>
<td>0.07</td>
<td>0.03</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.20</td>
<td>-0.03</td>
<td>0.02</td>
<td>0.02</td>
</tr>
<tr>
<td>Price Change %</td>
<td>1.0%</td>
<td>8.0%</td>
<td>-3.0%</td>
<td>-3.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1747256613_0.png" alt="eps graph" />
<h3>Tracking American Shared Hospital's Stock Performance</h3>
Shares of American Shared Hospital were trading at $2.85 as of May 13. Over the last 52-week period, shares are down 10.51%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release. 
<a href="https://www.benzinga.com/quote/AMS/earnings">To track all earnings releases for American Shared Hospital visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Examining the Future: American Shared Hospital's Earnings Outlook

DXC Technology Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DXC#NYSE">DXC</a>) released its fourth-quarter results after Wednesday's closing bell. Here's a look at the key figures<a href="https://www.benzinga.com/pressreleases/25/05/b45420485/dxc-technology-reports-fourth-quarter-and-full-year-fiscal-2025-results"> from the quarter. </a>
The Details: DXC Technology reported quarterly earnings of 84 cents per share, which beat the consensus estimate of 77 cents. Quarterly revenue clocked in at $3.17 billion, which beat the Street estimate of $3.13 billion.
Read Next: <a href="https://www.benzinga.com/news/large-cap/25/05/45414265/nvidia-climbs-on-saudi-ai-investments-analyst-estimates-15-billion-to-20-billion-in-revenue?utm_source=articleShare">Nvidia Climbs On Saudi AI Investments: Analyst Estimates $15 Billion To $20 Billion In Revenue&nbsp;</a>
&#8220;Our fourth quarter results represent continued progress toward our goal of achieving sustained, profitable revenue growth,&#8221; said DXC Technology CEO Raul Fernandez.
&#8220;For the second consecutive quarter, we reported bookings growth of more than 20% and book to bill ratios of greater than 1. While the macro backdrop remains uncertain, we&#8217;re staying focused on our priorities, delivering our deep and broad capabilities to our customers, driving performance with a newly energized and engaged employee base, and continuing to build a culture of accountability, collaboration and urgency,&#8221; Fernandez said.
Outlook: DXC Technology sees first-quarter adjusted EPS of between 55 cents and 65 cents per share, versus the 77 cent analyst estimate, and revenue in a range of $3.04 billion to $3.09 billion, versus the $3.12 billion estimate.
DXC sees fiscal 2026 adjusted EPS of&nbsp;between $2.75 and $3.25, versus the $3.41&nbsp;analyst estimate, revenue in a range of $12.18 billion to $12.44 billion, versus the&nbsp;$12.41 billion&nbsp;estimate.
DXC Price Action: According to data from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, DXC Technology stock was down 13.04% at $14.40 after-hours Wednesday.  
Read Next:&nbsp;
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/earnings/25/05/45353123/quantum-stocks-are-hot-in-2025-biggest-movers-to-watch?utm_source=articleShare">Quantum Stocks Are Hot In 2025: Biggest Movers To Watch&nbsp;</a></li>
</ul>
Image: Shutterstock

Tech

DXC Technology Stock Drops After Q4 Results, Q1 Guidance Below Estimates

Bridgeline Digital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLIN#NASDAQ">BLIN</a>) is set to give its latest quarterly earnings report on Thursday, 2025-05-15. Here's what investors need to know before the announcement.
Analysts estimate that Bridgeline Digital will report an earnings per share (EPS) of $0.00. 
Investors in Bridgeline Digital are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
<h3>Performance in Previous Earnings</h3>
Last quarter the company missed EPS by $0.01, which was followed by a 11.62% drop in the share price the next day.
Here's a look at Bridgeline Digital's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.05</td>
<td>-0.01</td>
<td>-0.04</td>
<td>-0.02</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.06</td>
<td>0</td>
<td>0</td>
<td>-0.02</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-12.0%</td>
<td>-14.000000000000002%</td>
<td>5.0%</td>
<td>-4.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1747256605_0.png" alt="eps graph" />
<h3>Market Performance of Bridgeline Digital's Stock</h3>
Shares of Bridgeline Digital were trading at $1.86 as of May 13. Over the last 52-week period, shares are up 67.13%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<a href="https://www.benzinga.com/quote/BLIN/earnings">To track all earnings releases for Bridgeline Digital visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BLIN

Examining the Future: Bridgeline Digital's Earnings Outlook

PRPO

Precipio Q1 EPS $(0.59) Up From $(1.46) YoY, Sales $4.93M Up From $3.43M YoY

Fluent (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLNT#NASDAQ">FLNT</a>) will release its quarterly earnings report on Thursday, 2025-05-15. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Fluent to report an earnings per share (EPS) of $-0.26.
The announcement from Fluent is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
<h3>Past Earnings Performance</h3>
Last quarter the company beat EPS by $0.05, which was followed by a 0.0% drop in the share price the next day.
Here's a look at Fluent's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.23</td>
<td>-0.08</td>
<td>-0.30</td>
<td>-0.08</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.18</td>
<td>-0.22</td>
<td>-0.47</td>
<td>-0.30</td>
</tr>
<tr>
<td>Price Change %</td>
<td>2.0%</td>
<td>-7.000000000000001%</td>
<td>-10.0%</td>
<td>-13.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1747256594_0.png" alt="eps graph" />
<h3>Performance of Fluent Shares</h3>
Shares of Fluent were trading at $2.41 as of May 13. Over the last 52-week period, shares are down 31.88%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release. 
<h3>Analysts' Take on Fluent</h3>
For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Fluent.
Analysts have provided Fluent with 1 ratings, resulting in a consensus rating of Neutral. The average one-year price target stands at $3.5, suggesting a potential 45.23% upside.
<h3>Comparing Ratings Among Industry Peers</h3>
In this comparison, we explore the analyst ratings and average 1-year price targets of and Fluent, three prominent industry players, offering insights into their relative performance expectations and market positioning.
<h3>Insights: Peer Analysis</h3>
Within the peer analysis summary, vital metrics for and Fluent are presented, shedding light on their respective standings within the industry and offering valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Fluent</td>
<td>Neutral</td>
<td>-10.11%</td>
<td>$13.90M</td>
<td>-15.27%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Fluent ranks at the bottom among peers in terms of consensus sentiment. It also shows the lowest revenue growth rate compared to peers. Additionally, its gross profit margin is the lowest in the group. Furthermore, Fluent's return on equity is the weakest among its peers.
<h3>Unveiling the Story Behind Fluent</h3>
Fluent Inc is a data-driven digital marketing services company. It performs customer acquisition services by operating digital marketing campaigns, through which it connects its advertiser clients with consumers company is seeking to reach. It delivers data and performance-based marketing executions to its clients, such as consumer brands, direct marketers and agencies across a wide range of industries, including Financial Products &amp; Services, Media &amp; Entertainment, Health &amp; Wellness, Staffing &amp; Recruitment and Retail &amp; Consumer.
<h3>Fluent: A Financial Overview</h3>
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Negative Revenue Trend: Examining Fluent's financials over 3 months reveals challenges. As of 31 December, 2024, the company experienced a decline of approximately -10.11% in revenue growth, reflecting a decrease in top-line earnings. When compared to others in the Communication Services sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Fluent's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -5.24% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Fluent's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of -15.27%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of -3.62%, the company showcases effective utilization of assets.
Debt Management: With a high debt-to-equity ratio of 1.5, Fluent faces challenges in effectively managing its debt levels, indicating potential financial strain.
<a href="https://www.benzinga.com/quote/FLNT/earnings">To track all earnings releases for Fluent visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

FLNT

Uncovering Potential: Fluent's Earnings Preview

VolitionRX (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/VNRX#AMEX">VNRX</a>) is set to give its latest quarterly earnings report on Thursday, 2025-05-15. Here's what investors need to know before the announcement.
Analysts estimate that VolitionRX will report an earnings per share (EPS) of $-0.04. 
The market awaits VolitionRX's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
<h3>Performance in Previous Earnings</h3>
During the last quarter, the company reported an EPS missed by $0.01, leading to a 9.03% drop in the share price on the subsequent day.
Here's a look at VolitionRX's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.05</td>
<td>-0.07</td>
<td>-0.09</td>
<td>-0.11</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.06</td>
<td>-0.07</td>
<td>-0.08</td>
<td>-0.10</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-9.0%</td>
<td>-6.0%</td>
<td>3.0%</td>
<td>-15.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1747256582_0.png" alt="eps graph" />
<h3>VolitionRX Share Price Analysis</h3>
Shares of VolitionRX were trading at $0.4678 as of May 13. Over the last 52-week period, shares are down 41.17%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release. 
<a href="https://www.benzinga.com/quote/VNRX/earnings">To track all earnings releases for VolitionRX visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

VNRX

VolitionRX Earnings Preview

P3 Health Partners (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PIII#NASDAQ">PIII</a>) is set to give its latest quarterly earnings report on Thursday, 2025-05-15. Here's what investors need to know before the announcement.
Analysts estimate that P3 Health Partners will report an earnings per share (EPS) of $-0.10. 
Investors in P3 Health Partners are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
<h3>Overview of Past Earnings</h3>
In the previous earnings release, the company missed EPS by $0.22, leading to a 4.59% drop in the share price the following trading session.
Here's a look at P3 Health Partners's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.17</td>
<td>-0.04</td>
<td>-0.05</td>
<td>-0.11</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.39</td>
<td>-0.31</td>
<td>-0.15</td>
<td>-0.16</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-5.0%</td>
<td>-36.0%</td>
<td>-4.0%</td>
<td>-2.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1747256553_0.png" alt="eps graph" />
<h3>Tracking P3 Health Partners's Stock Performance</h3>
Shares of P3 Health Partners were trading at $8.19 as of May 09. Over the last 52-week period, shares are down 72.74%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<h3>Analyst Opinions on P3 Health Partners</h3>
Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on P3 Health Partners.
Analysts have provided P3 Health Partners with 1 ratings, resulting in a consensus rating of Buy. The average one-year price target stands at $20.0, suggesting a potential 144.2% upside.
<h3>Comparing Ratings Among Industry Peers</h3>
The below comparison of the analyst ratings and average 1-year price targets of Biodesix, DocGo and AirSculpt Technologies, three prominent players in the industry, gives insights for their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Buy trajectory for Biodesix, with an average 1-year price target of $1.88, suggesting a potential 77.05% downside.</li>
<li>Analysts currently favor an Buy trajectory for DocGo, with an average 1-year price target of $3.59, suggesting a potential 56.17% downside.</li>
<li>Analysts currently favor an Neutral trajectory for AirSculpt Technologies, with an average 1-year price target of $2.5, suggesting a potential 69.47% downside.</li>
</ul>
<h3>Insights: Peer Analysis</h3>
The peer analysis summary presents essential metrics for Biodesix, DocGo and AirSculpt Technologies, unveiling their respective standings within the industry and providing valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Vivos Therapeutics</td>
<td>Buy</td>
<td>13.85%</td>
<td>$2.10M</td>
<td>-36.20%</td>
</tr>
<tr>
<td>Biodesix</td>
<td>Buy</td>
<td>39.28%</td>
<td>$16.09M</td>
<td>-33.86%</td>
</tr>
<tr>
<td>DocGo</td>
<td>Buy</td>
<td>-50.01%</td>
<td>$30.85M</td>
<td>-2.98%</td>
</tr>
<tr>
<td>AirSculpt Technologies</td>
<td>Neutral</td>
<td>-17.32%</td>
<td>$23.42M</td>
<td>-3.64%</td>
</tr>
</tbody>
</table>

Key Takeaway:
P3 Health Partners ranks at the top for Revenue Growth among its peers. It is at the bottom for Gross Profit and Return on Equity. The Consensus rating for P3 Health Partners is not provided in the data.
<h3>Get to Know P3 Health Partners Better</h3>
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.
<h3>Understanding the Numbers: P3 Health Partners's Finances</h3>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Positive Revenue Trend: Examining P3 Health Partners's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 6.87% as of 31 December, 2024, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Health Care sector.
Net Margin: P3 Health Partners's net margin excels beyond industry benchmarks, reaching -15.81%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of -59.68%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): P3 Health Partners's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -7.25% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 2.19, caution is advised due to increased financial risk.
<a href="https://www.benzinga.com/quote/PIII/earnings">To track all earnings releases for P3 Health Partners visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

PIII

What to Expect from P3 Health Partners's Earnings

Press Releases

Aurora Opens Advanced Lidar Research and Testing Facility in Bozeman, Montana

Aurora, Continental, and NVIDIA Partner to Deploy Driverless Trucks at Scale

Aurora to Host Fourth Quarter 2024 Business Review Conference Call on February 12, 2025

Aurora to Present at Canaccord Genuity Sustainability Summit

Aurora Announces Fourth Quarter 2024 Results

Aurora to Present at Cantor Global Technology Conference

Aurora Releases Safety Report in Preparation for Driverless Trucking

Aurora to Host First Quarter 2025 Business Review Conference Call on May 8, 2025

Aurora Begins Commercial Driverless Trucking in Texas, Ushering in a New Era of Freight

Comments

Aurora Innovation

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL